Title |
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
|
---|---|
Published in |
ClinicoEconomics and Outcomes Research: CEOR, September 2012
|
DOI | 10.2147/ceor.s34832 |
Pubmed ID | |
Authors |
Steen M Rønborg, Ulrik G Svendsen, Jesper S Micheelsen, Lars Ytte, Jakob N Andreasen, Lars Ehlers |
Abstract |
Grass pollen-induced allergic rhinoconjunctivitis constitutes a large burden for society. Up to 20% of European and United States (US) populations suffer from respiratory allergies, including grass pollen-induced allergic rhinoconjunctivitis. The majority of patients are treated with symptomatic medications; however, a large proportion remains uncontrolled despite use of such treatments. Specific immunotherapy is the only treatment documented to target the underlying cause of the disease, leading to a sustained effect after completion of treatment. The aim of this study was to compare the economic consequences of treating patients suffering from allergic rhinoconjunctivitis with either a grass allergy immunotherapy tablet (AIT) or subcutaneous immunotherapy (SCIT). |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Argentina | 1 | 20% |
Unknown | 4 | 80% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Scientists | 1 | 20% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Austria | 1 | 5% |
Unknown | 21 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 6 | 27% |
Student > Master | 5 | 23% |
Other | 3 | 14% |
Student > Bachelor | 2 | 9% |
Student > Doctoral Student | 1 | 5% |
Other | 1 | 5% |
Unknown | 4 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 7 | 32% |
Business, Management and Accounting | 2 | 9% |
Economics, Econometrics and Finance | 2 | 9% |
Chemistry | 2 | 9% |
Agricultural and Biological Sciences | 1 | 5% |
Other | 4 | 18% |
Unknown | 4 | 18% |